Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn’s disease
Michael Schmid(Robert Bosch Hospital), Jan Wehkamp(Robert Bosch Hospital), Eduard F. Stange(John Radcliffe Hospital), Klaus Fellermann(Apple (Israel)), Oliver Wiedow(Christian-Albrechts-Universität zu Kiel), Péter Fritz(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology)
Cited by 113
Related Papers
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566
European evidence-based Consensus on the management of ulcerative colitis: Current management
|Journal of Crohn s and Colitis|2008|558